Pharmac has added the weight-loss drug Wegovy to its list of medicines for potential future funding, with eligibility for people with high BMI and comorbidities, raising hopes for broader access and potential healthcare cost savings.
Stacked weekly counts; colour by editorial lean. Stuff and The Spinoff lean centre-left, NZ Herald centre-right, others centre.
How press outlets have named this topic, week by week.
Most recent 2 articles linking to this topic.
Up to 12 framings spread across outlets. Each framing is the LLM's one-line characterisation of the article's editorial angle — not a quote.
weight loss reduces long-term medical costs
Funding of weight-loss drug Wegovy expected to come swiftlybillions saved through reduced illness
Poor indoor air quality costing the country a billion dollars each year researchers saySocial-media signal on the same topic, drawn from the social lens. Engagement is likes + 2×shares + 3×replies, the same weighting used across the digest cards. View on /social →
Spotted something wrong on this page? Report a correction.
